Beyond the Virus: Post-COVID Hip Damage Driving Surge in Surgeries Among Young Indians

NEW DELHI — A troubling secondary health crisis is unfolding in the wake of the COVID-19 pandemic. Leading orthopaedic specialists in India are reporting a stark rise in severe, debilitating hip damage among young and middle-aged adults, leading to a dramatic spike in joint replacement surgeries for a demographic typically considered too young for such procedures.

At the recent 2nd Annual Delhi HIP 360 Conference held in New Delhi, medical experts sounded the alarm, revealing that some hospitals have experienced an estimated 40% increase in hip replacement surgeries among younger patients. The culprit behind this trend is avascular necrosis (AVN) of the femoral head—a painful condition where the blood supply to the ball portion of the hip joint is disrupted, causing the bone tissue to die and eventually collapse.

The Silent Progression: What Doctors Are Observing

Avascular necrosis, also known as osteonecrosis, is notoriously deceptive. According to clinical data from the Mayo Clinic, AVN often develops silently in its initial stages. As the disease progresses, patients begin to experience deep pain in the groin, thigh, or buttock. Initially, this discomfort may only manifest during weight-bearing activities like walking or running, but as the bone further deteriorates, the pain can become constant, occurring even while at rest.

“We are observing a 40 per cent rise in hip replacement surgeries in younger people,” stated Dr. L. Tomar, organizing chairman of DELHI HIP 360 and director of orthopaedics and joint replacement at Max Hospital, New Delhi.

Dr. Tomar warned that due to the insidious nature of the condition, a growing number of patients in their 30s and 40s are arriving at clinics only after the femoral head has already collapsed, resulting in advanced, severe arthritis. This shift is particularly concerning to health systems, as hip replacements in young adults present long-term challenges, including the likelihood that the artificial joints will wear out and require complex revision surgeries later in life.

Unraveling the Link: Why COVID-19 Matters

To understand why a respiratory virus is causing joint failure, researchers have focused on two primary mechanisms: the life-saving treatments used during the pandemic and the biological effects of the virus itself.

[COVID-19 Infection / Treatment]
       │
       ├─► High-Dose Corticosteroid Use ──┐
       │                                   ▼
       └─► Blood Clotting & Inflammation ──► Disrupted Blood Supply ──► Bone Tissue Death (AVN)

1. The Role of Corticosteroids

During the peak of the pandemic, corticosteroids (such as dexamethasone) were widely prescribed to curb life-threatening lung inflammation in moderate-to-severe COVID-19 cases. While these medications saved countless lives, high-dose or prolonged steroid exposure is a well-established risk factor for bone necrosis.

A 2023 systematic review published in Rheumatology International analyzed 14 studies involving 104 patients who developed femoral head AVN following a COVID-19 infection. The study found:

• The mean age of affected patients was remarkably young: 42.2 years.

• Corticosteroid use was documented in 13 out of the 14 reports analyzed.

• The average duration from a COVID-19 diagnosis to the detection of AVN was approximately 142 days (roughly four to five months).

2. The Viral Impact on Blood Vessels

However, steroids do not tell the whole story. Medical literature indicates that some patients developed AVN despite having no documented history of steroid treatment. Emerging research suggests that COVID-19 itself may directly injure blood vessels. The virus causes systemic inflammation, endothelial injury (damage to the lining of blood vessels), and a hypercoagulable state—meaning it makes the blood more prone to clotting. Small blood vessels supplying the hip joint can become blocked by microscopic clots, starving the bone of oxygenated blood.

A comprehensive 2024 review published in the journal Diagnostics concluded that the association between COVID-19, steroid therapy, and hip AVN is a meaningful public health concern, though it stressed that the interaction between viral pathology and drug side effects remains complex and multifactorial.

Public Health Implications and Practical Advice

For the general public, the primary takeaway from orthopaedic experts is vigilance, not panic. Corticosteroids remain an indispensable, essential tool for treating a wide array of severe medical conditions. The objective is to eliminate casual, unprescribed, or unmonitored use of these medications.

From a diagnostic standpoint, early intervention is critical. Standard X-rays frequently fail to detect AVN in its infancy. Magnetic Resonance Imaging (MRI) is the gold standard for spotting the condition early, well before structural failure occurs. If caught early, joint-preserving techniques—such as core decompression or bone grafting—can be utilized to save the natural hip. Once the femoral head collapses, total hip replacement often becomes the only viable option to restore mobility.

Limitations of Current Evidence

While the clinical observations from leading Indian institutions are alarming, epidemiologists urge a balanced interpretation of the data.

• Observational Data: The cited “40% increase” reflects institutional and conference-level observations rather than statistics from a unified, nationwide peer-reviewed registry. It serves as a vital clinical warning sign rather than an exact national statistic.

• No Established Thresholds: Currently, there is no single, proven steroid dosage or treatment duration that definitively predicts who will develop bone damage. The 2024 Diagnostics review noted that across various multi-study analyses, no clear, linear relationship was identified between cumulative steroid doses and the severity or onset of AVN.

Because the condition is multifactorial—dependent on an individual’s genetic predisposition, lifestyle factors, and the severity of the viral infection—further large-scale, long-term cohort studies are urgently needed to fully map out the precise risk factors.

What Readers Should Look Out For

If you or a loved one are recovering from a severe bout of COVID-19, particularly one that required hospitalization or steroid therapy, monitor your musculoskeletal health closely. Consult a healthcare professional immediately if you experience:

• Persistent pain in the groin, hip, or buttock that lasts beyond two to three weeks.

• Pain that intensifies when putting weight on the leg or during walking.

• A newly developed limp or a noticeable stiffness that reduces your hip’s range of motion.

Catching avascular necrosis before the bone structurally fails remains the single best way to protect your natural joint and avoid the operating table.

Medical Disclaimer

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• Hindustan Times / PTI. Post-Covid hip damage fuels 40 pc rise in surgeries among young Indians: Experts. Published May 24, 2026.